Ardelyx (ARDX) Change in Receivables (2013 - 2026)
Ardelyx's (ARDX) quarterly Change in Receivables came in at $11.0 million in Q1 2026, up 197.81% YoY from $3.7 million in Q1 2025, and up 330.83% on a QoQ basis from -$4.8 million in Q4 2025.
Ardelyx (ARDX) Change in Receivables (2013 - 2026) Analysis & Trends
Ardelyx (ARDX) has 11 years of Change in Receivables data on file, last reported at $11.0 million in Q1 2026.
- Quarterly Change in Receivables rose 197.81% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.4 million (up 98.71% YoY) and the FY2025 annual result came in at $14.1 million, down 60.35% from the prior year.
- Change in Receivables rose to $11.0 million in Q1 2026, from -$4.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $34.2 million in Q3 2023 to a low of -$21.2 million in Q4 2023.
- A 5-year average of $4.8 million and a median of $4.4 million in 2023 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 8329.88% in 2023, down 940.87% in 2023.
- Tracing ARDX's Change in Receivables over 5 years: stood at $2.5 million in 2022, then slumped by 940.87% to -$21.2 million in 2023, then jumped by 121.24% to $4.5 million in 2024, then slumped by 205.59% to -$4.8 million in 2025, then soared by 330.83% to $11.0 million in 2026.
- The last three Change in Receivables figures came in at $11.0 million (Q1 2026), -$4.8 million (Q4 2025), and $14.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 17.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.51 Mn |
| Jun 30, 2026 | 17.51 Mn |
| Mar 31, 2026 | 10.99 Mn |
| Mar 31, 2026 | 10.99 Mn |
| Dec 31, 2025 | -4.76 Mn |
| Dec 31, 2025 | -4.76 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 16.09 Mn |
| Jun 30, 2025 | 16.09 Mn |
| Mar 31, 2025 | -11.24 Mn |
| Mar 31, 2025 | -11.24 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Dec 31, 2024 | 4.51 Mn |
| Sep 30, 2024 | 15.95 Mn |
| Sep 30, 2024 | 15.95 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 6.13 Mn |
| Mar 31, 2024 | 6.13 Mn |